Literature DB >> 30259377

The Role of Circular RNAs in Cerebral Ischemic Diseases: Ischemic Stroke and Cerebral Ischemia/Reperfusion Injury.

Jian Yang1, Mengli Chen2, Richard Y Cao1, Qing Li1, Fu Zhu3.   

Abstract

Cerebral ischemic diseases including ischemic stroke and cerebral ischemia reperfusion injury can result in serious dysfunction of the brain, which leads to extremely high mortality and disability. There are no effective therapeutics for cerebral ischemic diseases to date. Circular RNAs are a kind of newly investigated noncoding RNAs. It is reported that circular RNAs are enriched in multiple organs, especially abundant in the brain, which indicates that circular RNAs may be involved in cerebral physiological and pathological processes. In this chapter, we will firstly review the pathophysiology, underlying mechanisms, and current treatments of cerebral ischemic diseases including ischemic stroke and cerebral ischemia/reperfusion injury. Secondly, the characteristics and function of circular RNAs will be outlined, and then we are going to introduce the roles circular RNAs play in human diseases. Finally, we will summarize the function of circular RNAs in cerebral ischemic diseases.

Entities:  

Keywords:  Cerebral ischemia/reperfusion injury; Cerebral ischemic diseases; Circular RNAs; Ischemic stroke

Mesh:

Substances:

Year:  2018        PMID: 30259377     DOI: 10.1007/978-981-13-1426-1_25

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  28 in total

Review 1.  BCL2L13: physiological and pathological meanings.

Authors:  Fei Meng; Naitong Sun; Dongyan Liu; Jia Jia; Jun Xiao; Haiming Dai
Journal:  Cell Mol Life Sci       Date:  2020-11-17       Impact factor: 9.261

2.  Improvement of cerebral ischemia-reperfusion injury by L-3-n-butylphthalide through promoting angiogenesis.

Authors:  Ying Huang; Lishou Pan; Ting Wu
Journal:  Exp Brain Res       Date:  2020-11-12       Impact factor: 1.972

Review 3.  Differential expression of non-coding RNAs and association with cerebral ischemic vascular disorders; diagnostic and therapeutic opportunities.

Authors:  Sharif Alhajlah
Journal:  Genes Genomics       Date:  2022-07-08       Impact factor: 1.839

4.  Overexpression of ORX or MCH Protects Neurological Function Against Ischemic Stroke.

Authors:  Gang Wu; Xi'an Zhang; Shijun Li; Dan Zhou; Jie Bai; Hanxiang Wang; Qing Shu
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

Review 5.  The Mechanism Underlying the Regulation of Long Non-coding RNA MEG3 in Cerebral Ischemic Stroke.

Authors:  Yanfang Zhao; Yingying Liu; Qili Zhang; Hongliang Liu; Jianing Xu
Journal:  Cell Mol Neurobiol       Date:  2022-01-06       Impact factor: 5.046

6.  circDlgap4 Alleviates Cerebral Ischaemic Injury by Binding to AUF1 to Suppress Oxidative Stress and Neuroinflammation.

Authors:  Huan Liu; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2022-03-16       Impact factor: 5.590

7.  Circular RNA circ_HECTD1 regulates cell injury after cerebral infarction by miR-27a-3p/FSTL1 axis.

Authors:  Zhenduo Zhang; Jinbo He; Baoliang Wang
Journal:  Cell Cycle       Date:  2021-04-12       Impact factor: 4.534

8.  CHRFAM7A Overexpression Attenuates Cerebral Ischemia-Reperfusion Injury via Inhibiting Microglia Pyroptosis Mediated by the NLRP3/Caspase-1 pathway.

Authors:  Xiangyuan Cao; Yida Wang; Liang Gao
Journal:  Inflammation       Date:  2021-01-06       Impact factor: 4.092

9.  Circular RNA PUM1 performs as a competing endogenous RNA of microRNA-340-5p to mediate DEAD-box helicase 5 to mitigate cerebral ischemia-reperfusion injury.

Authors:  Teng Hu; Di Li; TiePing Fan; XuSheng Zhao; ZhongJun Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

10.  miR-380-5p facilitates NRF2 and attenuates cerebral ischemia/reperfusion injury-induced neuronal cell death by directly targeting BACH1.

Authors:  Yibiao Wang; Min Xu
Journal:  Transl Neurosci       Date:  2021-05-18       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.